Yahoo
NYSE American - Delayed Quote USD

Apimeds Pharmaceuticals US, Inc. (APUS)

2.4200 -0.0900 (-3.59%)
At close: September 4 at 4:00:00 PM EDT
2.3500 -0.0700 (-2.89%)
After hours: September 4 at 7:47:00 PM EDT
Chart Range Bar
Loading chart for APUS
  • Previous Close 2.5100
  • Open 2.4900
  • Bid 2.3200 x 10000
  • Ask 2.4500 x 30000
  • Day's Range 2.4200 - 2.6000
  • 52 Week Range 2.4000 - 59.7000
  • Volume 24,333
  • Avg. Volume 71,388
  • Market Cap (intraday) 3.652M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -35.9800
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.

www.mindwavedao.com

--

Full Time Employees

--

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

APUS
85.24%
S&P 500 (^GSPC)
12.75%

1-Year Return

APUS
86.99%
S&P 500 (^GSPC)
18.71%

3-Year Return

APUS
93.95%
S&P 500 (^GSPC)
70.93%

5-Year Return

APUS
93.95%
S&P 500 (^GSPC)
70.18%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (5yr expected)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    -35.9800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: